21st May 2009 16:59
|
For Immediate Release |
21 May 2009 |
SkyePharma PLC ("the Company")
Conversion of £50,000 6% 2024 Bonds
Additional Listing
Application will be made to the UK Listing Authority and to the London Stock Exchange for an additional 13,477 Ordinary Shares of £1.00 each to be admitted to the Official List and to the London Stock Exchange's market for listed securities. The additional Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares.
These shares will be issued following the conversion of £50,000 of 6% 2024 Convertible Bonds at a conversion price of £3.71.
Following the issue, SkyePharma's issued share capital as at 28 March 2009 will consist of 23,269,308 Ordinary Shares.
Related Shares:
SKP.L